Philips and Masimo partner to advance access to patient monitoring technologies
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Subscribe To Our Newsletter & Stay Updated